Experience

ImmuneBiotech AB

• Sweden
• Biotechnology Research
• 1 - 100 Employee

• CBO

  • Jan 2016 - Present

  ImmuneBiotech AB - a microbiome company uniquely placed to develop therapeutically effective probiotic products designed using scientific and pharmacologic methods.Our products are scientifically designed combinations of safe probiotic strains. We have a technology platform to select and combine lactobacilli strains to have impact on important pathological alterations, such as: gut microbial dysbiosis, intestinal permeability and mucosal/systemic inflammation. We have access to a library of 150 unique probiotic strains as a base for designing powerful probiotic products.GutMagnificGutMagnific is our first product, scientifically designed for Irritable Bowel Syndrome (IBS) with market launch as a food supplement in 2019. GutMagnific is a patent pending multi-strain combination of probiotic lactobacilli strains.GutMagnificTM is expected to be effective on several gut related symptoms including IBS, Myalgic Encephalomyelitis also called Chronic Fatigue Syndrome (ME/CFS), and Clostridium difficile infection (CDI).http://www.immunebiotech.comhttps://www.gutmagnific.com/



Vetenskaps Fabriken AB

• Co Founder and Owner

  • Apr 2014 - Present

  Support in Business Development, specialties:• Business Strategies and Business Plans• Competitive landscapes • In-and Out-Licensing, identifying leads/opportunities /partners• Agreements and Negotiations• Evaluations using NPV methods• Preparing external materials• Preparing for Due Diligence Support in Business Development, specialties:• Business Strategies and Business Plans• Competitive landscapes • In-and Out-Licensing, identifying leads/opportunities /partners• Agreements and Negotiations• Evaluations using NPV methods• Preparing external materials• Preparing for Due Diligence



in2cure

• Sweden
• Medical Equipment Manufacturing

• Business Development Consultant

  • 2015 - Present



Alligator Bioscience AB

• Sweden
• Biotechnology Research
• 1 - 100 Employee

• Director Business Development

  • Mar 2002 - Oct 2015

  Active in the partnering of Alligator Bioscience’s internal drug candidates in immuno-oncology. Involved in the whole process from the identifying and selecting potential customers/partners, arranging meetings, and preparing documents, negotiations and setting up deals.Responsible for Search & Evaluation of new opportunities. Particularly focused on preclinical - phase I oncology assets (proteins and antibodies).Responsible for the sales and marketing of Alligators technology platform. Active in Alligators discover unit.Responsible for business intelligence, market analysis and valuations (rdNPV models).Responsible for CRM system.



Bioglan AB

• Sweden
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Senior Scientist & Project manager

  • May 1998 - Apr 2002

  Manager of a project to develop new adjuvant for vaccines. Formulated substances for controlled and sustained release of bio-pharmaceuticals.Planned in vitro and vivo studiesInvolved in the business development. Manager of a project to develop new adjuvant for vaccines. Formulated substances for controlled and sustained release of bio-pharmaceuticals.Planned in vitro and vivo studiesInvolved in the business development.



Novo Nordisk

• Denmark
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Scientist, Project Manager

  • Oct 1992 - Dec 1997

  In charge of a process development project.Formulation of proteins (lipases in particular).Coordinator of EU project. In charge of a process development project.Formulation of proteins (lipases in particular).Coordinator of EU project.



Pierre and Marie Curie University

• France
• Research
• 700 & Above Employee

• Post-doctoral fellow

  • Jan 1991 - May 1992

  Investigated interactions between proteins and liquid surfaces. Proteins were chemically modified to change there isoelectric point and these new proteins were used to study thelocalization of the proteins and physical effect on the emulsion system. Investigated interactions between proteins and liquid surfaces. Proteins were chemically modified to change there isoelectric point and these new proteins were used to study thelocalization of the proteins and physical effect on the emulsion system.